Differential effects of defibrillation on systemic and cardiac sympathetic activity

Heart

Volumn 79, Issue 6, 1998, Pages 560-567

  Bode, F ^a   Wiegand, U ^a   Raasch, W ^a   Richardt, G ^a   Potratz, J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Autonomic cardiac function; Catecholamines; Defibrillation; Lactate

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; ETOMIDATE; FENTANYL; MIDAZOLAM;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RESPONSE; CARDIOVERSION; CLINICAL ARTICLE; DEFIBRILLATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART VENTRICLE FIBRILLATION; HUMAN; LACTATE BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; SINUS RHYTHM; SYMPATHETIC TONE; TREATMENT INDICATION;

EID: 0031838838     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.6.560     Document Type: Article

References (40)

1. Eysmann SB, Marchlinski FE, Buxton AE, et al. Electrocardiographic changes after cardioversion of ventricular arrhythmias. Circulation 1986;73:73-81.
2. Waldecker B, Brugada P, Zehender M, et al. Dysrhythmias after direct-current cardioversion. Am J Cardiol 1986; 57:120-3.
3. Yabe S, Smith WM, Daubert JP, et al. Conduction disturbances caused by high current density electric fields. Circ Res 1990;66:1190-203.
4. Anderson GJ, Reiser J. Electrophysiologic changes induced by external transthoracic countershock. J Electrocardiol 1983;16:191-8.
5. Jones JL, Lepeschkin E, Jones RE, et al. Response of cultured myocardial cells to countershock-type electric field stimulation. Am J Physiol 1987;235:H214-22.
6. Pansegrau DG, Abboud FM. Hemodynamic effects of ventricular defibrillation. J Clin Invest 1970;49:282-97.
7. Ten Eick RE, Wyte SR, Ross SM, et al. Post-countershock arrhythmias in untreated and digitalized dogs. Circ Res 1967;21:375-90.
8. Cobb FR, Wallace AG, Wagner GS. Cardiac inotropic and coronary vascular responses to countershock. Evidence for excitation of intracardiac nerves. Circ Res 1968;23:731-42.
9. Yu JCL, Lauer MR, Young C, et al. Ventricular pacing threshold and refractoriness after defibrillation shocks in patients with implantable cardioverter-defibrillators. Am Heart J 1996;131:1121-6.
10. Ruffy R, Schechtman K, Monje E. Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, nonanaesthetized dogs. Circulation 1986;73:374-80.
11. Rattes MF, Sharma AD, Klein GJ, et al. Adrenergic effects on internal defibrillation threshold. Am J Physiol 1987;253: H500-6.
12. Reison D, Oliver JA, Sciacca RR, et al. Release of norepinephrine from sympathetic nerve efferents by bilateral carotid occlusion. Am J Physiol 1983;245:H635-9.
13. Remme WJ, Kruyssen DA, Look MP, et al. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans. J Am Coll Cardiol 1994;23:82-91.
14. Richardt G, Muench G, Neumann FJ, et al. Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction. Basic Res Cardiol 1997;92:52-60.
15. Morady F, DiCarlo LA, Halter JB, et al. The plasma catecholamine response to ventricular tachycardia induction and external countershock during electrophysiologic testing. J Am Coll Cardiol 1986;8:584-91.
16. Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990;70:963-85.
17. Esler M, Jennings G, Korner P, et al. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984;247:E21-2.
18. Wesley RC, Porzio D, Sadeghi M. Effect of selective A1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: evidence for an antiadrenergic role of endogenous adenosine. Cardiovasc Res 1993;27:129-33.
19. Hjemdahl P. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1987; 142:521-34.
20. Raasch W, Grobecker H, Kees F. Influence of ciprofloxacin on brain metabolism of biogenic amines in the rat. Pharm Pharmac Lett 1992;2:153-6.
21. Clutter WE, Bier DM, Shah SD, et al. Epinephrine plasma metabolic clearance rates and physiological thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980;66:94-101.
22. Peronnet F, Nadeau R, Boudreau G, et al. Epinephrine release from the heart during left stellate ganglion stimulation in dogs. Am J Physiol 1988;254:R659-62.
23. Salerno DM, Katz A, Dunbar DN, et al. Serum electrolytes and catecholamines after cardioversion from ventricular tachycardia and atrial fibrillation. PACE 1993;16:1862-71.
24. Esler M. Clinical application of norepinephrine spillover methodology: delineation of regional human sympathetic nervous responses. Pharmacol Toxicol 1993;73:243-53.
25. Manoach M, Varon D, Erez M. The role of catecholamines on intercellular coupling, myocardial cell synchronization and self ventricular defibrillation. Mol Cell Biochem 1995;147:181-5.
26. Cousineau D, Goresky CA, Bach GG, et al. Effect of β-blockade on in vivo norepinephrine release in canine heart. Am J Physiol 1984;246:H283-92.
27. Runsio M, Rosenqvist M, Bergfeldt L, et al. Cardiac outflow of endothelin, neuropeplide Y and noradrenaline in relation to hyperemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man. Eur Heart J 1995;16:1925-9.
28. Lucy SD, Jones DL, Klein GJ. Effects of defibrillation shocks delivered over a major coronary artery. PACE 1992; 15:1711-19.
29. Gertz EW, Wisneski JA, Neese R, et al. Myocardial lactate extraction: multi-determined metabolic function. Circulation 1980;61:256-61.
30. Gaba DM, Maxwell MS, Merlone S, et al. Internal counter-shock produces myocardial damage and lactate production without myocardial ischemia in anesthetized dogs. Anesthesiology 1987;66:477-82.
31. Trouton TG, Allen JD, Adgey AAJ. Oxidative metabolism and myocardial blood flow changes after transthoracic DC countershocks in dogs. Eur Heart J 1992;13:1431-40.
32. Haneda T, Ichihara K, Abiko Y, et al. Release of adenosine and lactate from human hearts during atrial pacing in patients with ischemic heart disease. Clin Cardiol 1989;12: 76-82.
33. Ito M, Pride HP, Zipes DP. Defibrillating shocks delivered to the heart impair efferent sympathetic responsiveness. Circulation 1993;88:2661-73.
34. Richardt G, Waas W, Kranzhöfer R, et al. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res 1987;61:117-23.
35. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-70.
36. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15(suppl A):9-16.
37. Crozier TA, Beck D, Schlaeger M, et al. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anaesthesiology 1987;66:628-35.
38. Glisson SN. Investigation of midazolam's influence on physiological and hormonal responses to hypotension. J Cardiovasc Pharmacol 1987;9:45-50.
39. Chraemmer-Jorgensen B, Hertel S, Strom J, et al. Catecholamine response to laryngoscopy and intubation. Anaesthesia 1992;47:750-6.
40. Krum H, Bigger T, Goldsmith RL, et al. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-94.